Skip to main content
    T

    Tenet Healthcare Corporation (THC)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $282.02
    -9.51 (-3.26%)

    Market Cap: $23.20B

    Last updated: Nov 17, 2026 at 4:31 PM ET

    Tenet Healthcare Corporation (THC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Tenet Healthcare (THC) has a market cap of $23.20B and an enterprise value of $33.77B. Its share count is down 8.89% from a year earlier. Its return on invested capital of 23.97% compares with a 14.52% median across 10 similar companies.

    Total Valuation

    Enterprise value is 45.55% above the market cap, as debt exceeds cash.

    Market Cap$23.20B
    Enterprise Value$33.77B
    Latest price (Nov 17, 2026)$282.02

    Key Dates

    The next earnings report is expected on Feb 9, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 9, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 4.06% in the quarter ended Sep 30, 2026 and shrank 8.48% a year over 2 years.

    Shares Outstanding80.13M
    Shares Change (YoY)-8.89%
    Shares Change (QoQ)-4.06%
    Share Count Growth (2Y CAGR)-8.48%

    Valuation Ratios

    Sales and book value multiples are 1.0x and 4.2x. Its year-end P/E ranged from 5.1x to 19.2x from 2016 to 2025.

    P/E Ratio12.7x
    Forward P/E12.3x
    P/S Ratio1.0x
    Forward P/S1.0x
    P/B Ratio4.2x
    P/FCF Ratio6.8x
    P/OCF Ratio5.5x
    PEG Ratio3.0

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 5.1x EBITDA and 10.0x free cash flow.

    EV / Earnings8.9x
    EV / Sales1.5x
    EV / EBITDA5.1x
    EV / EBIT6.1x
    EV / FCF10.0x

    Price Statistics

    The stock is up 46.20% over 52 weeks and trades 4.90% above its 50-day average.

    Beta (1Y)0.58
    52-Week Change+46.20%
    1-Month Change+5.87%
    3-Month Change+5.03%
    6-Month Change+47.35%
    5-Year Change+281.31%
    10-Year Change+1286.35%
    Total Return (1Y)+46.20%
    Total Return (3Y CAGR)+64.15%
    Total Return (5Y CAGR)+29.12%
    Return vs SPY (1Y)+34.57%
    Max Drawdown (1Y)-34.08%
    Max Drawdown (3Y)-34.48%
    Sharpe Ratio (1Y)0.90
    Correlation with SPY (1Y)0.19
    50-Day Average$268.84
    200-Day Average$225.81
    52-Week Range$157.58 to $301.44
    RSI (14 Days)53.5
    Average Volume (20 Days)919.26K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.58x current liabilities, and total debt is 2.43x shareholder equity.

    Current Ratio1.58x
    Quick Ratio1.52x
    Debt / Equity2.43x
    Debt / EBITDA2.05x
    Debt / FCF3.98x
    Interest Coverage6.73x

    Returns and Efficiency

    Return on invested capital is 23.97% over the last 12 months, against a 5-year average of 16.08%.

    Return on Equity (ROE)70.06%
    Return on Assets (ROA)12.07%
    Return on Invested Capital (ROIC)23.97%
    Return on Capital Employed (ROCE)21.15%
    ROE (5Y Average)93.26%
    ROA (5Y Average)7.14%
    ROIC (5Y Average)16.08%
    Asset Turnover0.73x
    Inventory Turnover25.96x
    Receivables Turnover8.52x
    Cash Conversion Cycle0 days

    Taxes

    Income tax took 19.40% of pretax income over the last 12 months.

    Income Tax (TTM)$918.00M
    Effective Tax Rate19.40%

    Scores

    THC has an Altman Z-Score of 2.32, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score2.32
    Altman Z ZoneGrey
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $22.15B over the last 12 months is up 6.22% from the 12 months before.

    Revenue$22.15B
    Revenue Growth (YoY)+6.22%
    Gross Profit$13.35B
    Operating Income$5.40B
    Pretax Income$4.73B
    Net Income$3.81B
    EBITDA$6.47B
    EBIT$5.56B
    Reported EPS (TTM)$22.28

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 17.22% of the $31.59B in total assets.

    Cash and Equivalents$2.67B
    Total Debt$13.24B
    Net Debt$10.57B
    Net Debt Per Share$131.89
    Working Capital$3.11B
    Shareholder Equity$5.44B
    Book Value Per Share$67.94
    Tangible Book Value-$7.42B
    Total Assets$31.59B
    Total Liabilities$22.00B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $910.00M of capital spending, operating cash flow left $3.33B of free cash flow.

    Operating Cash Flow$4.24B
    Capital Expenditures$910.00M
    Free Cash Flow$3.33B
    FCF Per Share$41.33
    Depreciation and Amortization$913.00M
    Share Repurchases$1.81B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 24.37%.

    Gross Margin60.28%
    Operating Margin24.37%
    Pretax Margin21.36%
    Net Margin17.22%
    EBITDA Margin29.21%
    EBIT Margin25.09%
    FCF Margin15.02%

    Growth

    Revenue grew 3.24% a year over 3 years, and EPS 34.93% a year.

    Revenue Growth (3Y CAGR)+3.24%
    Revenue Growth (5Y CAGR)+2.84%
    EPS Growth (3Y CAGR)+34.93%
    EPS Growth (5Y CAGR)+16.26%
    FCF Growth (3Y CAGR)+99.01%
    FCF Growth (5Y CAGR)-2.47%
    Operating Income Growth (3Y CAGR)+14.56%
    Book Value Per Share Growth (2Y CAGR)+76.34%

    Revenue and profit by year

    Dividends and Yields

    THC does not pay a dividend. Its free cash flow yield is 14.73%.

    Earnings Yield7.87%
    FCF Yield14.73%
    Buyback Yield8.02%
    Shareholder Yield14.33%

    Stock Splits

    The last split was a 1-for-4 reverse split on Oct 11, 2012.

    Last Split DateOct 11, 2012
    Split TypeReverse split
    Split Ratio1:4

    Peer Position

    Against 12 similar companies, THC has the 8th highest P/E and the 9th highest P/S.

    P/E Ratio12.7x vs 18.8x median
    P/S Ratio1.0x vs 1.4x median
    ROIC23.97% vs 14.52% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.22% vs +7.19% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 2.77% and EPS growth at 10.04% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+2.77%
    EPS Growth Forecast (2Y CAGR)+10.04%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About THC

    What is THC's market cap?

    Tenet Healthcare has a market cap of $23.20B. Its enterprise value, which adds debt and subtracts cash, is $33.77B.

    What is THC's P/E ratio?

    Tenet Healthcare has a trailing P/E ratio of 12.7x and a forward P/E of 12.3x.

    How many shares of THC are outstanding?

    Tenet Healthcare has 80.13M shares outstanding. The count is down 8.89% from a year earlier.

    Does THC pay a dividend?

    No. Tenet Healthcare does not pay a dividend.

    How much debt does THC have?

    Tenet Healthcare has $13.24B of total debt and $2.67B of cash and equivalents, a net debt position of $10.57B.